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ABSTRACT
The PubMed R© database of biomedical citations al-
lows the retrieval of scientific articles studying the
function of chemicals in biology and medicine. Min-
ing millions of available citations to search reported
associations between chemicals and topics of in-
terest would require substantial human time. We
have implemented the Alkemio text mining web
tool and SOAP web service to help in this task.
The tool uses biomedical articles discussing chem-
icals (including drugs), predicts their relatedness
to the query topic with a naı¨ve Bayesian classifier
and ranks all chemicals by P-values computed from
random simulations. Benchmarks on seven human
pathways showed good retrieval performance (areas
under the receiver operating characteristic curves
ranged from 73.6 to 94.5%). Comparison with exist-
ing tools to retrieve chemicals associated to eight
diseases showed the higher precision and recall
of Alkemio when considering the top 10 candidate
chemicals. Alkemio is a high performing web tool
ranking chemicals for any biomedical topics and it
is free to non-commercial users. Availability: http:
//cbdm.mdc-berlin.de/∼medlineranker/cms/alkemio.
INTRODUCTION
Associating chemicals with biological functions (e.g. dis-
ease, metabolism or proliferation) allows biomedical re-
searchers to understand or predict roles of chemicals in bi-
ological pathways and diseases. As PubMed (1), the main
database of biomedical citations, contains millions of en-
tries, it might not be possible to manually derive such as-
sociations. Automatically mining the literature using text
mining algorithms offers comprehensive and predictive
searches.
Using predictive text mining algorithms through web in-
terfaces or web services could help biomedical scientists
in various applications. For example, it could be useful in
defining a list of thousands of chemicals for a screening ex-
periment, in extending available data on molecular path-
ways, in retrieving the most relevant chemicals related to
a disease or in predicting chemicals for poorly studied dis-
eases. Available text mining tools allow computing associa-
tion of chemicals with defined topics. However, query top-
ics could be restricted to given biological dictionaries (e.g.
CoPub (2)), and tools handling free-text queries could be
limited by computing resources (e.g. PolySearch (3)) or may
not rank candidate chemicals (e.g. EBIMed (4)).
Based on gene-citation links, it was demonstrated pre-
viously that fast and accurate ranking of all genes of a
species for given biomedical topics can be achieved by the
Ge´nie text mining algorithm (5). Ge´nie associates genes to
biomedical topics by classifying the gene-related PubMed
citations using theMedlineRanker algorithm (6). TheMed-
lineRanker document classification algorithm implements
a naı¨ve Bayesian classifier that models biases in word usage
in a set of PubMed citations related to a topic of interest.
Applying a similar approach than Ge´nie to rank chemicals
may produce accurate results and be of broad interest to
biomedical researchers because query topics are not limited
and simply defined as sets of related citations.
Based on Ge´nie, MedlineRanker and chemical anno-
tations of PubMed citations, we have implemented the
Alkemio web tool that ranks all annotated chemicals (in-
cluding drugs) in the literature for any biomedical top-
ics. The method was benchmarked using known molecular
pathway-related chemicals and compared to existing tools
using disease-related chemicals. Alkemio is freely available
to non-commercial users.
MATERIALS AND METHODS
Implementation
The Alkemio algorithm uses PubMed citations with En-
glish abstracts. PubMed citations are manually annotated
using the Medical Subject Headings thesaurus (MeSHR©)
(1). MeSH provides a controlled vocabulary organized as a
tree with 16 branches under the root level such as anatomy,
organisms, diseases, and chemicals and drugs. For each
PubMed citation, two sets of MeSH terms were extracted:
the main MeSH terms used to characterize the content of
the citation (from tags MeshHeadingList) and the chemi-
cal MeSH terms with non-zero registry numbers (from tags
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ChemicalList). The latter is used to define a list of chemical
names to be ranked; the former and the latter are used to se-
lect a set of citations defining the topic of interest as an alter-
native to a free-text query to PubMed. The following types
of chemicals were not used: enzymes and coenzymes (MeSH
tree number D08), proteins (MeSH tree number D12.776)
and multiprotein complexes (MeSH tree number D05.500).
As of 3 April 2014, we could extract a total of 8 877 369
chemical–PubMed links for 50 394 chemicals.
Alkemio retrieves PubMed citations related to the in-
put chemical list using their annotation by chemical MeSH
terms and classifies them usingMedlineRanker as related to
the input topic or not. Results of Alkemio are summarized
by chemical and sorted by false discovery rates (FDRs). P-
values andFDRs are computed from a simulation on 10 000
random citations. The approach is similar to the ranking of
genes implemented in the Ge´nie algorithm.
Alkemio uses the MedlineRanker document classifica-
tion algorithm that was previously published (see for de-
tails (6,7)). Briefly, nouns are extracted by a part-of-speech
processor from titles and abstracts downloaded from the
PubMed XML files (tags ArticleTitle and AbstractText).
A stop word list is used to filter out common and non-
informative nouns. Provided a training set composed of ci-
tations related to a topic of interest and a background set
composed of random citations, MedlineRanker produces a
weighted list of discriminative nouns. Weights are defined
by naı¨ve Bayesian statistics. This weighted list of nouns is
then used to score other citations; each noun matching one
in the list would add its weight (only once) to the total score.
Scores are converted into P-values thanks to random sim-
ulations and a P-value cutoff is used to decide if a citation
is related to the topic of interest or not. If the query topic is
defined by aMeSH term and the sameMeSH term is found
in the manual annotations of a citation, this citation will be
automatically set as relevant to the topic by associating to
it a P-value equal to zero.
Web pages were built withWordPress 3.8 or programmed
using HTML 4, JavaScript, PHP and Perl 5.10.1. Data were
stored in a MySQL 5.1.41 database. Web pages were tested
using various web browsers (Firefox 26, Chrome 31, In-
ternet Explorer 10 and Safari 7) and operating systems
(Ubuntu 12.04 and 12.10,Windows XP and Seven andMac
OS X 10.9).
Pathway benchmark
To benchmark Alkemio, data about all (n= 7) human path-
ways involving at least 10 chemicals identified by a Chem-
ical Abstracts Service (CAS) registry number were down-
loaded fromWikiPathways (8) on 11March 2013. Alkemio
ranked all chemicals for each pathway with default param-
eters (using as input the result of a query to PubMed, using
the quoted pathway name, ranking chemicals from citations
from the last 3 years, using a P-value cutoff for abstract
selection equal to 0.01 and a FDR cutoff equal to 0.001).
Alkemio ranks were transformed into scores using the fol-
lowing formula: score = sqrt(1/rank). Alkemio returned a
total of 10 356 candidate chemicals. Registry numbers were
either converted to CAS numbers if provided as FDA SRS’s
UNIIs (File UNIIs 18Nov2013 Records.txt from http://
fdasis.nlm.nih.gov/srs/download/srs/UNII Data.zip) (n =
1803) or removed from the candidate list if provided as En-
zyme Commission numbers (n = 28). Because there were
very few known positives in comparison to the number of
candidates, the ranking performance was evaluated with the
QiSampler tool (9). QiSampler parameters were set to 1000
repetitions and a sampling rate of 50%. Note that due to
the low number of positive cases, control curves may not
start as theoretically expected at coordinates (0,0) and end
at (1,1).
Comparison
In order to compare Alkemio with existing tools (FACTA
(10) and PolySearch (3)), we used data from the Compara-
tive ToxicogenomicsDatabase (CTD) as gold standard (11).
FACTA and PolySearch were chosen because they accept
any topic as input and they rank the candidate chemicals.
The CTD data were downloaded on 4 September 2013, and
contained a total of 56 907 chemicals with a CAS number
and 67 817manually set associations between chemicals and
diseases. As input to query the tools, we selected eight dif-
ferent diseases represented by the following MeSH terms:
Alzheimer’s disease (AD) (72 associations with chemicals),
anemia (215 associations), arthritis rheumatoid (77 associ-
ations), diabetes mellitus (57 associations), meningitis (40
associations), pancreatitis (83 associations), porphyrias (12
associations) and purpura (37 associations). Due to the low
minimal number of known associations for a selected dis-
ease (minimum= 12) and the variable amount of candidates
returned by the different tools (minimum= 33), we focused
the comparison to the top 10 candidates retrieved from each
tool, although we also analyzed the top 100 if enough can-
didates were available.
The CAS numbers were used for mapping the candi-
date chemicals to CTD. The tools did not report only
CAS numbers but also FDA SRS’s UNIIs (Alkemio),
KEGG (FACTA), DrugBank (FACTA and PolySearch)
and HMDB identifiers (PolySearch). Conversion to
CAS was done using data from FDA SRS, DrugBank
(http://www.drugbank.ca/system/downloads/current/
drugbank.txt.zip and http://www.drugbank.ca/system/
downloads/current/drug links.csv.zip) (12), HMDB
(http://www.hmdb.ca/downloads/hmdb metabolites.zip)
(13), and results of a manual query to the Chemical
Translation Service (14) to convert KEGG identifiers. The
percentage of candidate chemicals associated to a CAS
number was 97.7 (n = 20 277) for Alkemio, 90.7 (n = 18
978) for FACTA and 87.5 (n= 1101) for PolySearch. Then,
we (i) removed chemicals not mapped to one of the 56 907
chemicals having a CAS registry number in CTD from the
lists of candidates, (ii) removed duplicate candidates for
each tool and disease keeping the one with the maximal
score and (iii) identified those candidates that agreed with
CTD chemical–disease associations as true positives.
Tools’ parameters were set to retrieve as many candidates
as possible in a reasonable time. Alkemio was queried on 2
April 2014, using its SOAP web service to rank chemicals
found in articles published during the last 3 years with a
P-value cutoff for abstract selection set to 0.01 and a FDR
cutoff set to 1. Alkemio’s FDRwas transformed into a score
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as follows: score = sqrt(1/rank). FACTA was queried on 2
April 2014, manually to retrieve all drugs and compounds
associated to the query sorted by Pointwise Mutual Infor-
mation. FACTA’s scores were transformed to be only pos-
itive, keeping the same ordering of the candidates (i.e. the
absolute value of the minimal score + 1 was added to all
scores). PolySearch was queried on 5November 2013, man-
ually to retrieve all drugs and metabolites associated to a
query disease. Polysearch’s automated disease synonym list
was used; searches were limited to a maximum of 10 000 ab-
stracts from the past 1 year of the PubMed database and the
minimumnumber of citations was set to 1. The PolySearch’s
rscore was used as the main score for the benchmark. Due
to very slow computations or technical problems, we had
to limit queries to PolySearch to using <10 000 abstracts,
and drug candidates for AD and arthritis rheumatoid used
the default parameters (all available PubMed abstracts, but
retrieved candidates limited to 2000).
RESULTS
Graphical user interface
The Alkemio algorithm that ranks chemicals for biomedi-
cal topics was implemented as a web server freely available
to non-commercial users. It is composed of an input form,
documentation and information pages. The topic of interest
is defined by a list of biomedical citations internally repre-
sented by their PubMed identifiers (PMIDs). The web in-
terface provides a facility to define this list either from a
list of exact MeSH terms (e.g. ‘Alzheimer Disease’, ‘Phos-
phorylation’ or ‘Stem Cells’) or from a free-text query to
PubMed (e.g. ‘early onset Alzheimer’s disease’). All chem-
icals linked to PubMed citations published during the last
year can be ranked. As of on 2 April 2014, this set of ci-
tations represents 8073 chemicals and 116 458 chemical–
PMID links. The search can be extended to 3 years to rank
16 017 chemicals using 828 992 chemical–PMID links (com-
puting time: 2–3 min). Alternatively, a smaller list of chem-
icals to be ranked can be defined with exact names from the
MeSH database. In this case, all their chemical–PMID links
are used (no limitation to the last 3 years). PubMed citations
are downloaded and updated daily, while chemical–PMID
links are computed monthly.
Two cutoff values can be defined by the user. First, the
FDR cutoff limits the displayed chemicals by significance.
Second, the P-value cutoff for the selection of abstracts is
used by a naı¨ve Bayesian classifier to decide if a PubMed
citation linked to a chemical is relevant to the topic of in-
terest. The lower this value, the higher the precision, but the
lower the recall of relevant citations. A default value is set
to 0.01, but different ways to define it automatically are pro-
posed optimizing the precision or the F score from internal
statistical simulations.
The output page contains mainly the ranked list of chem-
icals that shows for each candidate a registry number, a
chemical name linked to an appropriate external MeSH en-
try page, the number of associated PMIDs, the number of
PMIDs classified as relevant to the topic (hits), the FDR
and a list of 10 top PMIDs having the lowest classifica-
tion P-values (Figure 1). Discriminative words and weights
used by the text mining classifier are shown in a table. A
file download section at the bottom provides results of the
analysis as text files with tab-separated values. Displayed
PMIDs are linked to a new window showing related title,
abstract, journal, authors, links to PubMed or full texts and
MeSHannotations. Discriminative words found in this win-
dow and names of the target chemical are highlighted in
brown or rose, respectively.
Web service
The Alkemio’s SOAP web service is designed for program-
matic access over the network. For example, computations
from Alkemio could be retrieved from another program or
a user could run batch queries. Using common program-
ming languages, a programmer can connect to the service
using a WSDL descriptor (http://cbdm.mdc-berlin.de/
tools/medlineranker/soap/wsdl/AlkemioSOAPbeta1.wsdl)
and call the main function with appropriate parameters (see
documentation on the web page). The output of Alkemio is
returned as XML data, which is valid against the Alkemio’s
DTD (http://cbdm.mdc-berlin.de/tools/medlineranker/
soap/dtd/alkemio beta1.dtd). The SOAP web service can
be used without programming with a client Perl script as
command line interface accepting files as inputs (e.g. for
topics or for a list of chemicals).
Benchmarks
Alkemio results for seven human pathways were compared
to chemicals known to have a role in these pathways in
WikiPathways (Table 1). Although few chemicals were re-
ported in each pathway (between 12 and 14), Alkemio re-
turned many candidates (between 545 and 2431). Thus, the
relevance of scores given to true positives was evaluated by
areas under receiver operating characteristic (ROC) curves
using a sampling strategy (9). Areas ranged from 73.6 to
94.5% (Table 1 and Figure 2).
We have also compared the performance of Alkemio
with FACTA and PolySearch when retrieving manually an-
notated known associations of chemicals and eight dis-
eases from the CTD database. In this comparison, Alkemio
queried using the PubMed option retrieved in average 897
candidates for a disease (minimum = 517 and maximum =
1561), Alkemio queried using the MeSH option retrieved
in average 1281 candidates for a disease (minimum = 684
and maximum= 3155), FACTA 1474 (minimum= 674 and
maximum= 2448) and PolySearch 109 (minimum= 33 and
maximum = 374). We compared the precision in the top 10
candidates for each tool and disease (Figure 3). Alkemio’s
precision ranged from 0.20 to 0.70 or 0.10 to 0.80 when it
was queried using the PubMed or the MeSH option, re-
spectively. Compared to FACTA and PolySearch, it had the
best reported precision in all eight (100%) cases (six times
alone and two times together with another tool) or in seven
(87.5%) cases (six times alone and one time together with
another tool) when it was queried using the PubMed or the
MeSH option, respectively.
Then, we compared the precision in the top 100 candi-
dates (Supplementary Figure S1). Compared to FACTA
and PolySearch, Alkemio had the best precision five or four
times when it was queried using the PubMed or the MeSH
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Figure 1. Alkemio’s output. As example, Alkemio was queried to retrieve AD chemicals on 31 March 2014. The topic was queried as a MeSH term
(Alzheimer Disease), citations from the last 3 years were used, the P-value cutoff for abstract selection equaled 0.01 and the FDR cutoff equaled 0.001.
The main result shown at the top of this figure is a table of ranked candidate chemicals with registry numbers (ID), names as MeSH terms, number of
related PubMed citations (PMIDs), number of PubMed citations classified as relevant to AD (hits), FDR and links to the 10 best PubMed citations (top
10 abstracts). PubMed citation links are displayed by level of confidence: highest level of confidence (manual validation; red heart symbols), high precision
(90% precision from random simulations; red diamonds), good precision (70% precision from random simulations; black spades) and others passing the
cutoff (black clubs). By clicking on a PubMed citation link, detailed information will be displayed in a new window (bottom right corner), including
abstract, MeSH terms, discriminative words (brown color gradient) and the target chemical name (rose highlighting). The output also contains the list of
discriminative words used by the document classifier (left-hand side), and a download section to retrieve the data as text tables (bottom left corner).
Table 1. Molecular pathway benchmark
Pathway
Known
chemicals Candidates True positives Recall
Area under ROC
curve
Biogenic amine synthesis 14 545 8 0.57 0.862
Cholesterol biosynthesis 14 1740 10 0.71 0.862
Monoamine transport 12 1563 9 0.75 0.945
Nucleotide metabolism 14 1952 11 0.79 0.926
One-carbon metabolism 12 1443 7 0.58 0.856
Tryptophan metabolism 14 2431 9 0.64 0.736
Urea cycle and metabolism of
amino groups
13 682 10 0.77 0.914
option, respectively. As PolySearch did not identify enough
candidates for six diseases, Alkemio was mostly compared
to FACTA. As we set the same number of candidates for
each tool, comparing other statistics such as the recall and
the F1 score leads to the same result (Supplementary Figure
S1).
Use case
We have illustrated the use of Alkemio with a query focused
on the study of the chemicals relevant to the topic of pro-
tein aggregate formation in the brain, an effect usually as-
sociated to neurodegenerative disease. To do this analysis,
we used Alkemio with default parameters (using as input
the result of a query to PubMed, ranking chemicals from
citations from the last 3 years, using a P-value cutoff for
abstract selection equal to 0.01 and a FDR cutoff equal to
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Figure 2. Molecular pathway benchmark. Alkemio was queried to retrieve chemicals related to seven molecular pathways. Pathways were selected from
the WikiPathways database if associated with >10 chemicals. Due to the low number of known chemicals in these pathways (from 12 to 14) and to the
high number of candidates returned by Alkemio (between 545 and 2431), we evaluated the retrieval performance using a random sampling strategy with
the QiSampler tool (9). The figure shows ROC curves (blue lines) and control curves from random simulations (dashed lines) produced by the QiSampler
tool when selecting 1000 repetitions and 50% of sampling rate. Legends show area under the curve.
Figure 3. Comparison with existing tools. Precision in the top 10 candi-
date chemicals retrieved by Alkemio, FACTA and PolySearch according
to manual associations between chemicals and diseases from the CTD
database. As the CTD data are not comprehensive, many true positives are
not automatically identified and the observed precision underestimates the
real precision.
0.001) using as input a query with the words protein, aggre-
gates and brain. This loosely defined query, nevertheless, se-
lected abstracts related to the intended topic as indicated by
the top ranked words that resulted: aggregate, tauopathie(s)
(a class of degenerative diseases associated to the aggrega-
tion of the protein tau), synuclein (a family of proteins of
which -synuclein is known to aggregate in AD) and hunt-
ingtin (the protein mutated in Huntington’s disease, a neu-
rodegenerative disease).
The list of chemicals included many strong associations
(Table 2). The reasons why these chemicals are relevant to
the topic of protein aggregates in neurodegeneration can
be easily examined by following the links to the abstracts,
whose words are colored according to their discriminative
power. Examination of the top ranked chemicals illustrates
the different types of implications they can have in the con-
text of the study of a disease.
The first ranked chemical was polyglutamine in reference
to polyglutamine tracts, a protein feature whose pathologi-
cal expansion results in several neurodegenerative diseases,
probably due to the alteration of protein interactions mod-
ulated by these tracts. The second chemical was dopamine,
which is depleted in the brains of Parkinson’s disease
patients. Others were oxidopamine (6-hydroxydopamine),
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-
phenylpyridinium, rotenone and glutamate, which are neu-
rotoxic compounds, often used to induce a Parkinson’s
disease-like phenotype in rats and mice. The following
chemicals were also returned: thioflavin T used as a fluo-
rescent marker in experiments, levodopa (L-DOPA) used to
treat Parkinson’s disease and 3-nitropropionic acid used to
cause mitochondrial dysfunction and neurodegeneration in
rodent models of Huntington’s disease.
Relevant bibliography is selected by Alkemio and can
be accessed by running this query (representative PubMed
records are indicated in Table 2). In summary, the chemicals
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Table 2. Top chemicals related to protein, aggregates and brain
Rank Chemical
Representative Alkemio selected
PMID Relation to topic
1 Polyglutamine 22433867 Mechanism
2 Dopamine 22967820 Marker
3 Oxidopamine 22016808 Toxin
4 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine
21448659 Toxin
5 Thioflavin T 21464905 Technical
6 Rotenone 21736921 Toxin
7 1-Methyl-4-phenylpyridinium 23754278 Toxin
8 Glutamic acid 22560595 Toxin
9 Levodopa 22764226 Protector
10 3-Nitropropionic acid 21448659 Toxin
obtained are relevant to the topic and their relation to neu-
rodegenerative disease (technical, part of the natural mech-
anism, marker, toxin or protector) can be easily understood
by examination of the top ranked references to PubMed.
If a focus on a particular category of chemicals is desired,
one may try to build more specific queries, but these have
to be constructed specifically for each topic. However, this
may not be too difficult after examining the bibliography
obtained in the first less specific step. For example, after
compiling the previous example, it became obvious that the
term ‘protective’ is used in the field of neurodegeneration
to define chemicals that are used for a beneficial effect as
opposed to toxins. Therefore, we illustrated the selection of
chemicals in a second step using the same parameters with a
query containing the following words: protein, aggregates,
brain and (additionally to the previous query) protective.
As before, the words were generally related to neurode-
generation with top weighed words such as aggregate, hunt-
ingtin, htt and synuclein. However, the top ranked chemi-
cals included compounds such as davunetide and clioquinol
(rank positions 3 and 6, respectively), used as therapeu-
tic agents, or marker 24-hydroxycholesterol (rank 5), af-
ter polyglutamine and oxidopamine, and only one toxin
(trimethyltin, rank 4).
In summary, Alkemio allows to quickly produce queries
of increased precision through the selection of links to rel-
evant PubMed records. Usually, examining one or two ab-
stracts suffices to understand the evidence behind the selec-
tion of a chemical in the ranked list.
DISCUSSION
The implementation of Alkemio as a web tool allows users
to rank tens of thousands of chemicals discussed in the re-
cent literature for any topic of interest. The SOAP web ser-
vice allows the programmatic usage of Alkemio (e.g. for
batch queries) from common programming languages or
from the provided client script. Building large lists of scored
candidates manually is impractical. Alkemio can provide in
a short time a list of hundreds or thousands of candidate
chemicals for a given topic. These candidates are scored by
the words from their related literature. Such large lists of
topic-related chemicals can have multiple uses such as in
supporting the analysis of molecular pathways or diseases.
A task for a biomedical scientist could be to find chem-
icals related to molecular pathways. Pathway data are ac-
cessible from dedicated databases (e.g. WikiPathways), but
it may not be up to date to the current literature. Here we
have shown that Alkemio can retrieve thousands of chemi-
cals associated to particular pathways, although only 12–14
were known in WikiPathways. The good ranking of those
known chemicals as assessed by ROC curves suggests that
the scored lists provided by Alkemio are appropriate for the
task.
Alkemio has better performance than existing tools
(FACTA (10) and PolySearch (3)) to retrieve disease-
associated chemicals. On the one hand, the tools tried to
retrieve all existing relevant chemicals from the literature;
on the other hand, the gold standards contained only a
limited selection of chemicals relevant for their purpose
(i.e. description of only key molecules involved in path-
ways for WikiPathways, or environmental chemicals in-
volved in diseases for marker, mechanism or therapeutic
role for CTD). Consequently, benchmarking the tools us-
ing those gold standards resulted in underestimated perfor-
mances, although they allowed an unbiased comparison.
For example, in the Alkemio’s top 10 candidates for AD
queried by a MeSH term, the following chemicals not au-
tomatically identified as true positives were found manu-
ally to be true positives: creatine (CAS: 57-00-1), which is
used to definemarkers in combination with other molecules
(15), oxidopamine (CAS: 1199-18-4), which was studied
in AD (16) and may have a mechanism in common with
the amyloid- peptide involved in AD (17), choline (CAS:
62-49-7), which had positive results on the disease as nu-
trient (18), dopamine (CAS: 51-61-6), which is linked to
non-cognitive aspects of dementia and target of known AD
drugs (19) and thioflavin T (CAS: 2390-54-7), which is used
in many studies in fluorescence assays to follow aggregation
or fibril formation (see e.g. (20)). Therefore, Alkemio’s pre-
cision for the top 10 ranked chemicals is actually 100% and
not 40% as automatically computed using CTD data.
The differences in performance between the tools may
be explained by the fact that, contrary to FACTA and
PolySearch, Alkemio does not rely on information extrac-
tion techniques to get associations between chemicals and
PubMed citations. Such techniques have limited accuracy
and are often used prior to manual validations (21,22).
Alkemio relies onmanually setMeSH (15) annotations that
may not be comprehensive, but that are of the highest qual-
ity. We note that the differing scoring schemes used by the
tools compared possibly had an impact on the results. In
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addition, it would be interesting to expand the benchmark
with more diseases and with other topics. As we have used
existing tools and their web interfaces (HTML pages), such
expansion would require considerably more manual work.
On the contrary, Alkemio could be automatically queried
using the client script to its SOAP web service.
Notably, results are sensitive to updates. The system is
updated daily and results may differ with time (e.g. new
citations could be linked to chemicals or citations may be
deleted from PubMed). Parameters have also an impact
on the ranking results. Defining the topic using a PubMed
query would model the topic using the most recent related
citations. Topics may be discussed differently over time. For
example, novel methods may be first technically described
and later just used in standard protocols. Defining the topic
using MeSH terms would model the topic more generally
because internally a random selection of related citations is
performed. The automatic selection of chemicals for rank-
ing can be done using citations from the last 1 or 3 years.
The former choice performs in a smaller dataset and, there-
fore, is faster, but will produce results biased toward recent
research trends; it could be useful for preliminary searches.
In general, the bigger the dataset, the more powerful the
statistics. Thus, we would recommend using citations from
the last 3 years to rankmany chemicals with Alkemio. Also,
chemicals having numerous citationsmay be favored in their
ranking simply because related statistics would be defined
from big numbers.
For the future, we plan to reduce Alkemio’s computing
time by running parallel computations. We would also try
to use citation metadata in addition to words in abstracts as
classification features. In conclusion, the Alkemio tool ac-
cessible from its web interface or SOAP web service ranks
with high performance chemicals related to a biomedical
topic of interest in practical time. Alkemio is freely acces-
sible to non-commercial users at the following URL: http:
//cbdm.mdc-berlin.de/∼medlineranker/cms/alkemio.
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